NASDAQ: BCRXBiocryst Pharmaceuticals Revenue
Biocryst Pharmaceuticals revenue was $503.49M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2025) ending on Mar 31, 2025 was $145.5M, up 10.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, BCRX annual revenue was $450.7M, with 36% growth year-over-year.
BCRX past revenue growth
How has BCRX's revenue growth performed historically?
Company
41.67%
Industry
1,361.15%
Market
34.96%
BCRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BCRX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BCRX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
BCRX revenue history
Current Revenue
$503.5M
Current Earnings
-$53.5M
Current Profit Margin
-10.6%
Be the first to know when BCRX announces revenue.
BCRX Revenue History By Year
| BCRX Yearly Revenue | BCRX Revenue | BCRX Change | BCRX Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $450.71M | $119.30M | +36.00% |
| 2023-12-31 | $331.41M | $60.59M | +22.37% |
| 2022-12-31 | $270.83M | $113.66M | +72.31% |
| 2021-12-31 | $157.17M | $139.36M | +782.38% |
| 2020-12-31 | $17.81M | -$31.02M | -63.53% |
| 2019-12-31 | $48.84M | $28.18M | +136.45% |
| 2018-12-31 | $20.65M | -$4.53M | -18.00% |
| 2017-12-31 | $25.19M | -$1.17M | -4.43% |
| 2016-12-31 | $26.35M | -$21.90M | -45.39% |
| 2015-12-31 | $48.26M | $34.65M | +254.62% |
| 2014-12-31 | $13.61M | -$3.72M | -21.48% |
| 2013-12-31 | $17.33M | -$8.96M | -34.09% |
| 2012-12-31 | $26.29M | $6.65M | +33.85% |
| 2011-12-31 | $19.64M | -$42.74M | -68.51% |
| 2010-12-31 | $62.38M | -$12.21M | -16.37% |
| 2009-12-31 | $74.59M | $18.03M | +31.87% |
| 2008-12-31 | $56.56M | -$14.68M | -20.60% |
| 2007-12-31 | $71.24M | $65.03M | +1,046.79% |
| 2006-12-31 | $6.21M | $6.06M | +3,990.38% |
| 2005-12-31 | $151.87k | -$185.03k | -54.92% |
| 2004-12-31 | $336.90k | -$316.35k | -48.43% |
| 2003-12-31 | $653.26k | N/A | N/A |
| 2002-12-31 | $0.00 | -$11.16M | -100.00% |
| 2001-12-31 | $11.16M | $3.50M | +45.64% |
| 2000-12-31 | $7.66M | $2.33M | +43.77% |
| 1999-12-31 | $5.33M | -$2.30M | -30.12% |
| 1998-12-31 | $7.63M | $4.93M | +183.23% |
| 1997-12-31 | $2.69M | $40.36k | +1.52% |
| 1996-12-31 | $2.65M | $1.77M | +199.82% |
| 1995-12-31 | $884.59k | $150.77k | +20.55% |
| 1994-12-31 | $733.82k | N/A | N/A |
Biocryst Pharmaceuticals Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.